Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1990 May;61(5):652–654. doi: 10.1038/bjc.1990.147

Adjuvant chemotherapy for early breast cancer.

I C Henderson 1
PMCID: PMC1971592  PMID: 2186772

Full text

PDF
652

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonadonna G., Valagussa P. Systemic therapy in resectable breast cancer. Hematol Oncol Clin North Am. 1989 Dec;3(4):727–742. [PubMed] [Google Scholar]
  2. Brincker H., Rose C., Rank F., Mouridsen H. T., Jakobsen A., Dombernowsky P., Panduro J., Andersen K. W. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer. J Clin Oncol. 1987 Nov;5(11):1771–1778. doi: 10.1200/JCO.1987.5.11.1771. [DOI] [PubMed] [Google Scholar]
  3. De Vita V. T., Jr Breast cancer therapy: exercising all our options. N Engl J Med. 1989 Feb 23;320(8):527–529. doi: 10.1056/NEJM198902233200812. [DOI] [PubMed] [Google Scholar]
  4. Fisher B., Fisher E. R., Redmond C. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. J Clin Oncol. 1986 Jun;4(6):929–941. doi: 10.1200/JCO.1986.4.6.929. [DOI] [PubMed] [Google Scholar]
  5. Fisher B., Redmond C., Dimitrov N. V., Bowman D., Legault-Poisson S., Wickerham D. L., Wolmark N., Fisher E. R., Margolese R., Sutherland C. A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors. N Engl J Med. 1989 Feb 23;320(8):473–478. doi: 10.1056/NEJM198902233200801. [DOI] [PubMed] [Google Scholar]
  6. Fisher B., Redmond C., Wickerham D. L., Bowman D., Schipper H., Wolmark N., Sass R., Fisher E. R., Jochimsen P., Legault-Poisson S. Doxorubicin-containing regimens for the treatment of stage II breast cancer: The National Surgical Adjuvant Breast and Bowel Project experience. J Clin Oncol. 1989 May;7(5):572–582. doi: 10.1200/JCO.1989.7.5.572. [DOI] [PubMed] [Google Scholar]
  7. Fornander T., Rutqvist L. E., Cedermark B., Glas U., Mattsson A., Silfverswärd C., Skoog L., Somell A., Theve T., Wilking N. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet. 1989 Jan 21;1(8630):117–120. doi: 10.1016/s0140-6736(89)91141-0. [DOI] [PubMed] [Google Scholar]
  8. Gelber R. D., Goldhirsch A. The concept of an overview of cancer clinical trials with special emphasis on early breast cancer. J Clin Oncol. 1986 Nov;4(11):1696–1703. doi: 10.1200/JCO.1986.4.11.1696. [DOI] [PubMed] [Google Scholar]
  9. Haybittle J. L., Brinkley D., Houghton J., A'Hern R. P., Baum M. Postoperative radiotherapy and late mortality: evidence from the Cancer Research Campaign trial for early breast cancer. BMJ. 1989 Jun 17;298(6688):1611–1614. doi: 10.1136/bmj.298.6688.1611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Henderson I. C. Adjuvant systemic therapy for early breast cancer. Curr Probl Cancer. 1987 May-Jun;11(3):125–207. [PubMed] [Google Scholar]
  11. Holland J. F. Editorial: Major advance in breast-cancer therapy. N Engl J Med. 1976 Feb 19;294(8):440–441. doi: 10.1056/NEJM197602192940809. [DOI] [PubMed] [Google Scholar]
  12. Mansour E. G., Gray R., Shatila A. H., Osborne C. K., Tormey D. C., Gilchrist K. W., Cooper M. R., Falkson G. Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study. N Engl J Med. 1989 Feb 23;320(8):485–490. doi: 10.1056/NEJM198902233200803. [DOI] [PubMed] [Google Scholar]
  13. McGuire W. L. Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989 Feb 23;320(8):525–527. doi: 10.1056/NEJM198902233200811. [DOI] [PubMed] [Google Scholar]
  14. McGuire W. L. Adjuvant therapy of node-negative breast cancer. N Engl J Med. 1989 Feb 23;320(8):525–527. doi: 10.1056/NEJM198902233200811. [DOI] [PubMed] [Google Scholar]
  15. Morrison J. M., Howell A., Kelly K. A., Grieve R. J., Monypenny I. J., Walker R. A., Waterhouse J. A. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. I. Patients with involved axillary lymph nodes. Br J Cancer. 1989 Dec;60(6):911–918. doi: 10.1038/bjc.1989.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Morrison J. M., Howell A., Kelly K. A., Grieve R. J., Monypenny I. J., Walker R. A., Waterhouse J. A. West Midlands Oncology Association trials of adjuvant chemotherapy in operable breast cancer: results after a median follow-up of 7 years. II. Patients without involved axillary lymph nodes. Br J Cancer. 1989 Dec;60(6):919–924. doi: 10.1038/bjc.1989.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Rosen P. R., Groshen S., Saigo P. E., Kinne D. W., Hellman S. A long-term follow-up study of survival in stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol. 1989 Mar;7(3):355–366. doi: 10.1200/JCO.1989.7.3.355. [DOI] [PubMed] [Google Scholar]
  18. Senn H. J., Barett-Mahler A. R., Jungi W. F., Osako Adjuvant chemoimmunotherapy with LMF + BCG in node-negative and node-positive breast cancer patients: 10 year results. Eur J Cancer Clin Oncol. 1989 Mar;25(3):513–525. doi: 10.1016/0277-5379(89)90265-4. [DOI] [PubMed] [Google Scholar]
  19. Smith I. Adjuvant tamoxifen for early breast cancer. Br J Cancer. 1988 Jun;57(6):527–528. doi: 10.1038/bjc.1988.122. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES